Resources

Enhancing Lentiviral Transduction Efficiency and Reducing MOI in Therapeutically Relevant Cell Types Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Optimizing AAV Production Efficiency: A Scalable Approach Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Small Molecule Antagonists of Cellular Innate Immunity for Enhanced Cell and Gene Therapy Manufacturing
June 14th, 2025PosterCell & Gene Therapies
Optimizing AAV Production: Accelerating Discovery of Small Molecule Enhancers using High Throughput Virology and Design of Experiments
May 10th, 2025PosterCell & Gene Therapies
End-to-End Optimization of CAR-T Manufacturing: Boosting Lentiviral Production and T-Cell Transduction with Viral Sensitizer Technology
May 10th, 2025PosterCell & Gene Therapies
High-Throughput Screening of Next Generation Small Molecule Enhancers and Process Automation in Cloud-Connected Bioreactors
April 20th, 2025PosterCell & Gene Therapies
Increased AAV Yield: From Screen to Scale Up to Cost Savings Using Viral Sensitizers (VSE™) Technology
April 20th, 2025PosterCell & Gene Therapies
Viral Sensitizers Unleash Host Cell Potential to Enhance AAV Production
April 20th, 2025PosterCell & Gene Therapies
Evaluation of Small Molecule Antagonists of Cellular Innate Immunity for T-cell Manufacturing
April 20th, 2025PosterCell & Gene Therapies
Harnessing the Power of High-Throughput Virology and DoE for Rapid Vector Optimization
April 20th, 2025PosterCell & Gene Therapies

Virica uses cookies to provide a better website experience of our website. I agree to the Privacy Policy and Terms of Use. OK